Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses the immune function by inducement programmed cell death of activated cytotoxic T cells that modify neoplasm progression within the human body. Additionally, exosomes additionally stimulate the angiogenesis and migration resulting in metastasis. Moreover, exosomes trigger apoptosis in anti-tumor immune cells through tumor necrosis factor pathways. Furthermore, health care professionals use exosomes to diagnose cancer, that helps in identification genetic changes in tumors and additionally stop unfold of the disease.
Experts feel, increase in prevalence of cancer, technological advancements, and rising stress on early identification of cancer area unit a number of the main factors driving market growth. However, lack of awareness and tight rules for the approval of merchandise employed in exosome-based analysis hamper the expansion of the market.
Market Insights
The global Exosome Diagnostics and Therapeutic market is expected to be around US$ 510 Million by 2028 at a CAGR of more than 29% in the given forecast period.
The global Exosome Diagnostics and Therapeutic market Based on Product Type the global Exosome Diagnostics and Therapeutic market is segmented in Instrument, Consumables & Reagents, and Software & Services. Based on End User the global Exosome Diagnostics and Therapeutic market is segmented in Cancer Institutes, Hospitals, Diagnostic Centers, and Others.
Based on Applications, the global Exosome Diagnostics and Therapeutic market is segmented in Diagnostic application and Therapeutic application.
The global Exosome Diagnostics and Therapeutic market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Exosome Diagnostics and Therapeutic market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Bio-Rad Laboratories, Inc., JN Medsys, Qiagen N.V., Expedeon AG, Sysmex Corporation, Fluidigm Corporation, Merck KGaA, Stilla Technologies, Thermo Fisher Scientific, Inc., Expedeon AG, and others are among the major players in the global Exosome Diagnostics and Therapeutic market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Exosome Diagnostics and Therapeutic Market has been segmented as below:
Exosome Diagnostics and Therapeutic Market, By Product Type
Exosome Diagnostics and Therapeutic Market, By End User
Exosome Diagnostics and Therapeutic Market, By Applications
Exosome Diagnostics and Therapeutic Market, By Region
Exosome Diagnostics and Therapeutic Market, By Company
The report covers:
Report Scope:
The global Exosome Diagnostics and Therapeutic market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Exosome Diagnostics and Therapeutic market share. Major industry players with significant revenue share include Bio-Rad Laboratories, Inc. , JN Medsys, Qiagen N.V. , Expedeon AG, Sysmex Corporation , Fluidigm Corporation, Merck KGaA, , Stilla Technologies, Thermo Fisher Scientific, Inc., Expedeon AG, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Exosome Diagnostics and Therapeutic Market, By Product Type
5.1 Introduction
5.2 Instrument
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Consumables & Reagents
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Software & Services
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6. Exosome Diagnostics and Therapeutic Market, By End User
6.1 Introduction
6.2 Cancer Institutes
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Hospitals
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Diagnostic Centers
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Others
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. Exosome Diagnostics and Therapeutic Market, By Applications
7.1 Introduction
7.2 Diagnostic application
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Therapeutic application
7.3.1 Market Overview
7.3.2 Market Size and Forecast
8. Exosome Diagnostics and Therapeutic Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Exosome Diagnostics and Therapeutic, By Product Type
8.2.2 North America Exosome Diagnostics and Therapeutic, By End User
8.2.3 North America Exosome Diagnostics and Therapeutic, By Applications
8.3 Europe
8.3.1 Europe Exosome Diagnostics and Therapeutic, By Product Type
8.3.2 Europe Exosome Diagnostics and Therapeutic, By End User
8.3.3 Europe Exosome Diagnostics and Therapeutic, By Applications
8.4 Asia-Pacific
8.4.1 Asia-Pacific Exosome Diagnostics and Therapeutic, By Product Type
8.4.2 Asia-Pacific Exosome Diagnostics and Therapeutic, By End User
8.4.3 Asia-Pacific Exosome Diagnostics and Therapeutic, By Applications
8.5 Rest of the World
8.5.1 Rest of the World Exosome Diagnostics and Therapeutic, By Product Type
8.5.2 Rest of the World Exosome Diagnostics and Therapeutic, By End User
8.5.3 Rest of the World Exosome Diagnostics and Therapeutic, By Applications
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 Bio-Rad Laboratories, Inc.
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 JN Medsys
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Qiagen N.V.
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Expedeon AG
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Sysmex Corporation
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Fluidigm Corporation
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Merck KGaA,
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Stilla Technologies
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Thermo Fisher Scientific, Inc.
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Expedeon AG
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The Exosome Diagnostics and Therapeutic Market has been segmented as below:
Exosome Diagnostics and Therapeutic Market, By Product Type
Exosome Diagnostics and Therapeutic Market, By End User
Exosome Diagnostics and Therapeutic Market, By Applications
Exosome Diagnostics and Therapeutic Market, By Region
Exosome Diagnostics and Therapeutic Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
